Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000806419 | SCV000946416 | uncertain significance | Immunodeficiency 67 | 2023-08-30 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The isoleucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 651127). This variant has not been reported in the literature in individuals affected with IRAK4-related conditions. This variant is present in population databases (rs766606181, gnomAD 0.003%). This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 457 of the IRAK4 protein (p.Met457Ile). |
Ambry Genetics | RCV004028243 | SCV004890822 | uncertain significance | Inborn genetic diseases | 2023-12-09 | criteria provided, single submitter | clinical testing | The c.1371G>A (p.M457I) alteration is located in exon 12 (coding exon 11) of the IRAK4 gene. This alteration results from a G to A substitution at nucleotide position 1371, causing the methionine (M) at amino acid position 457 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |